You are here

Novartis

Novartis' latest Zolgensma data bode well for use in older patients

Fierce Pharma

Mon, 10/7/19 - 12:13 pm

spinal muscular atrophy

It May Be Time For Standard Breast Cancer Treatment To Change

Forbes

Sun, 10/6/19 - 12:44 pm

HER2-negative breast cancer

A Key Novartis Drug Could Be Delayed — Why This Stock Is Cheering

Investors Business Daily

Sat, 10/5/19 - 02:17 pm

Coherus Biosciences

Novartis stacks more positive PhIII data on Cosentyx franchise — eyeing approval in non-radiographic axial spondyloarthritis

Endpoints

Wed, 10/2/19 - 10:54 am

axial spondyloarthritis

Why Bausch Health Companies Stock Sank Today

Motley Fool

Tue, 10/1/19 - 11:01 pm

Novartis and Microsoft announce collaboration to transform medicine with artificial intelligence

Globe Newswire

Tue, 10/1/19 - 11:11 am

artificial intelligence

drug development

ESMO: Eyeing Novartis and Pfizer, Chi-Med touts neuroendocrine cancer win

Fierce Pharma

Mon, 09/30/19 - 10:38 am

neuroendocrine tumors. ESMO

Novartis announces positive results from asthma combinations

Pharmaforum

Mon, 09/30/19 - 10:32 am

clinical trials

Blow to Novartis as NICE rejects migraine drug Aimovig again

Pharmaforum

Thu, 09/26/19 - 10:54 am

GlaxoSmithKline halts generic Zantac supply as global threat gains steam

Fierce Pharma

Thu, 09/26/19 - 10:50 am

product recalls

Novartis to put AveXis into protective custody after data manipulation scandal

Fierce Pharma

Tue, 09/24/19 - 10:17 pm

Novartis in political row after denying Belgian toddler compassionate access to gene therapy

Pharmaforum

Tue, 09/24/19 - 10:01 am

compassionate use guidelines

Novartis, shadowed by data scandal, renews case for Zolgensma

Biopharma Dive

Thu, 09/19/19 - 09:56 am

spinal muscular atrophy

Biogen ramps up its SMA rivalry with Novartis with new Spinraza trial

Fierce Pharma

Wed, 09/18/19 - 11:21 am

clinical trials

spinal muscular atrophy

Half-Off Sale! Five Major Drugmakers Reveal Vast Gross-to-Net Price Gaps—and Why Rebate Reform Is Still Needed

Drug Channels

Tue, 09/17/19 - 03:35 pm

Novartis’ Cosentyx heads for fourth indication after supportive data in early ankylosing spondylitis

Pharmaforum

Tue, 09/17/19 - 10:18 am

ankylosing spondylitis

Amplyx Inks Novartis Deal for Another Compromised-Immune System Drug

Xconomy

Tue, 09/17/19 - 10:12 am

immune deficiency

Three Breast Cancer Drugs: FDA Warns of Rare but Serious Lung Inflammation

RAPS.org

Sun, 09/15/19 - 09:47 pm

Novartis backs brolucizumab with new head-to-head Eylea trial

Pharmaforum

Mon, 09/9/19 - 08:15 pm

clinical trials

age-related macular degeneration

Novartis Makes New Data Integrity Commitment

RAPS.org

Mon, 09/9/19 - 11:22 am

Pages